- A randomized trial of Convalescent Plasma in Covid-19 Severe Pneumonia found no significant differences in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo. https://www.nejm.org/doi/full/10.1056/nejmoa2031304 3 comments science
- Plasma from people who recover from COVID-19 doesn't help new patients: No significant differences observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo. Publication in the New England Journal of Medicine http://www.doi.org/10.1056/nejmoa2031304 19 comments science
Linking pages
- How India’s COVID-19 crisis became the worst in the world https://www.sciencenews.org/article/coronavirus-covid-india-crisis-social-distancing-masks-variant 6 comments
- Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial | BMC Infectious Diseases | Full Text https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06348-5 4 comments
- Coronavirus Drug and Treatment Tracker - The New York Times https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.html 0 comments
- Study Says Blood Plasma Reduces Risk of Severe Covid-19 if Given Early - The New York Times https://www.nytimes.com/2021/01/06/health/convalescent-plasma-covid.html 0 comments
Linked pages
Related searches:
Search whole site: site:doi.org
Search title: A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia | NEJM
See how to search.